Companies:
49,943
Total Market Cap:
142461776308253.83
Global Rank
#3262
Country Rank
#66
Market Cap
5.26 B
Price
120.16
Change (%)
0.42%
Volume
46,457
Siegfried Holding AG's latest marketcap:
5.26 B
As of 07/26/2025, Siegfried Holding AG's market capitalization has reached $5.26 B. According to our data, Siegfried Holding AG is the 3262th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 5.26 B |
| Revenue (ttm) | 1.63 B |
| Net Income (ttm) | 201.39 M |
| Shares Out | 43.77 M |
| EPS (ttm) | 4.64 |
| Forward PE | 27.24 |
| Ex-Dividend Date | 04/22/2025 |
| Earnings Date | 08/21/2025 |
Market Cap Chart
Data Updated: 07/26/2025
Siegfried Holding AG's yearly market capitalization.
Siegfried Holding AG has seen its market value grow from ₣629.82 M to ₣4.18 B since 2014, representing a total increase of 563.67% and an annual compound growth rate (CAGR) of 19.60%.
| Date | Market Cap(₣) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/26/2025 | ₣4.18 B | $5.26 B | -1.58% | 3262 |
| 12/30/2024 | ₣4.23 B | $4.66 B | 15.85% | 3162 |
| 12/29/2023 | ₣3.65 B | $4.34 B | 40.13% | 3222 |
| 12/30/2022 | ₣2.61 B | $2.82 B | -29.96% | 4223 |
| 12/30/2021 | ₣3.72 B | $4.08 B | 37.52% | 3781 |
| 12/30/2020 | ₣2.7 B | $3.05 B | 38.4% | 4089 |
| 12/30/2019 | ₣1.95 B | $2.02 B | 38.87% | 4560 |
| 12/28/2018 | ₣1.41 B | $1.43 B | 10.68% | 4944 |
| 12/29/2017 | ₣1.27 B | $1.3 B | 51.12% | 6032 |
| 12/30/2016 | ₣841.36 M | $824.62 M | 7.06% | 7335 |
Company Profile
Siegfried Holding AG Overview
Siegfried Holding AG, together with its subsidiaries, operates as a global leader in contract development and manufacturing for active pharmaceutical ingredients (APIs) and finished dosage forms.
Core Offerings
- Drug Substances: Custom API manufacturing (exclusive synthesis) and a broad API portfolio, including non-exclusive APIs and pharma-grade substances.
- Specializations: Anesthetics, pain and addiction treatment, central nervous and respiratory diseases, and caffeine for human health and nutrition.
Drug Products
- Steriles: Fill and finish in vials, ampoules, cartridges, and pre-filled syringes.
- Ophthalmics: Sterile ointments, gels, suspensions, and solutions.
- Inhalation Products: Capsules in medical devices for inhalation applications.
- Oral Solid Dosage Forms: Tablets and capsules.
- Viral Vectors: AAV and lentiviruses for gene therapy.
Technologies & Services
- Chemistry capabilities and analytical services.
- Formulation and bridging technologies.
- Containment technology.
- Cell and gene therapies.
Founded: 1873 | Headquarters: Zofingen, Switzerland
Frequently Asked Questions
-
What is Siegfried Holding AG's (SWX-SFZN) current market cap?As of 07/26/2025, Siegfried Holding AG (including the parent company, if applicable) has an estimated market capitalization of $5.26 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Siegfried Holding AG (SWX-SFZN) rank globally by market cap?Siegfried Holding AG global market capitalization ranking is approximately 3262 as of 07/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.